Galicaftor (ABBV-2222)

Catalog No.S8535 Synonyms: GLPG2222

For research use only.

Galicaftor (ABBV-2222, GLPG2222) is a potent corrector of CFTR for the treatment of Cystic Fibrosis (CF).

Galicaftor (ABBV-2222) Chemical Structure

CAS No. 1918143-53-9

Purity & Quality Control

Choose Selective CFTR Inhibitors

Other CFTR Products

Biological Activity

Description Galicaftor (ABBV-2222, GLPG2222) is a potent corrector of CFTR for the treatment of Cystic Fibrosis (CF).
Targets
CFTR [1]
In vitro

ABBV-2222/GLPG2222 exhibits potent in vitro functional activity in primary patient cells harboring F508del/F508del CFTR with an EC50 <10 nM. ABBV-2222 promotes maturation of F508delCFTR, and stabilizes nucleotide binding domain 1 - membrane spanning domain interface. ABBV-2222 corrects F508delCFTR through action on membrane spanning domain 1.[2]

Protocol (from reference)

Cell Research:

[2]

  • Cell lines: CFBE41o-F508del CFTR-HRP cells
  • Concentrations: 0 - 20 μM
  • Incubation Time: 18-24 h
  • Method:

    the CFBE41o-F508del CFTR-HRP cells are plated in 384-well plates at 4,000 cells/well along with 0.5 μg/mL doxycycline to induce the F508del CFTR-HRP expression and further incubated at 37 oC, 5% CO2 for 72 hours. ABBV-2222/GLPG2222 is then added at the required concentrations and further incubated for 18-24 hours at 33 °C. The highest concentration tested is 20 μM with an 8-12 point concentration response curve using a 3-fold dilution.

Solubility (25°C)

In vitro

Chemical Information

Molecular Weight 559.46
Formula

C28H21F4NO7

CAS No. 1918143-53-9
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles C1CC1(C2=CC3=C(C=C2)OC(O3)(F)F)C(=O)NC4CC(OC5=C4C=CC(=C5)OC(F)F)C6=CC=C(C=C6)C(=O)O

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Galicaftor (ABBV-2222) | Galicaftor (ABBV-2222) supplier | purchase Galicaftor (ABBV-2222) | Galicaftor (ABBV-2222) cost | Galicaftor (ABBV-2222) manufacturer | order Galicaftor (ABBV-2222) | Galicaftor (ABBV-2222) distributor